Trial Profile

Second Phase II trial of ZYN001 in patients with fibromyalgia and peripheral neuropathic pain.

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 31 Mar 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ZYN 001 (Primary)
Indications Fibromyalgia; Neuropathic pain
Focus Therapeutic Use

Most Recent Events

31 Mar 2017 New trial record
27 Mar 2017 This trial is expected to begin in the second half of 2017, according to a Zynerba Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com